about 200 million doses behind where we want to be because of the interruption of supply out of india because of the need to redirect them there and also because of the challenge that were having getting other manufacturers to scale up and come online early enough such as the johnson and johnson producthe said while there are commitments in principle of about 150 million doses to be donated through covax there are two big problems with thatnumber one very little of it is committed for the junejuly period which means were going to still have this gap the other problem is just the volume if we are going to get on track to get at least 3040 per cent of the world vaccinated this year we got to get another 250 million people vaccinated between now and the end of septemberwe expect india sii serum institute of india volumes to open up again in the fourth quarter at least he said adding that countries are going to fail unless they get vaccines early to start rolling out building community confidence building their systems but were setting up for failure if we dont get early dosesthe serum institute of india sii the worlds largest vaccine manufacturer is the key supplier of astrazeneca doses to covax however supply of vaccines from sii to covax has been impacted as the second wave of the covid19 pandemic ravages indialast month ghebreyesus had said that once the devastating outbreak in india recedes we also need the serum institute of india to get back on track and catch up on its delivery commitments to covaxin response to a question on the situation in india and nepal which are seeing devastating surges in covid cases he said are we concerned about india and nepal absolutely weve got escalating epidemics in different parts of india still its going down overall but some areas are still hard hitin nepal too areas are hard hit still real gaps in terms of what they need to be able to save lives in real time as well as protect people with vaccines so as we look for doses and bringing the doses forward the goal is to be able to get more doses surged into these places that are being hit so that we can reduce the risk of death in the face of these escalating outbreaks as well